Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

Detalles Bibliográficos
Autores principales: Bruce, Ian N, Golam, Sarowar, Steenkamp, Jason, Wang, Pearl, Worthington, Evelyn, Desta, Barnabas, Psachoulia, Konstantina, Erhardt, Wilma, Tummala, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2022
Materias:
Letter in Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288956/
https://www.ncbi.nlm.nih.gov/pubmed/36515083
http://dx.doi.org/10.2217/cer-2022-0192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288956/
https://www.ncbi.nlm.nih.gov/pubmed/36515083
http://dx.doi.org/10.2217/cer-2022-0192

Ejemplares similares